| Field | Specification |
|---|---|
| UniProt # | |
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of Mouse Ang-Ⅱ concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Mouse Ang-Ⅱ. During the reaction, Mouse Ang-Ⅱ in the sample or standard competes with a fixed amount of Mouse Ang-Ⅱ on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Mouse Ang-Ⅱ. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Mouse Ang-Ⅱ in tested samples can be calculated by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 9.38 pg/mL |
|---|---|
| Detection Range | 15.63-1000 pg/mL |
| Total Assay Time | 2 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Mouse |
| Detection Method | Competitive |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Mouse Ang-Ⅱ in samples.No significant cross-reactivity or interference between Mouse Ang-Ⅱ and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 9.38 pg/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 2 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Competitive ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant Ang-Ⅱ standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Myeloid ACE2 protects against septic hypotension and vascular dysfunction through Ang-(1–7)-Mas-mediated macrophage polarization (2023) Redox Biology. 10.1016/j.redox.2023.103004
Circadian light/dark cycle reversal exacerbates the progression of chronic kidney disease in mice (2024) JOURNAL OF PINEAL RESEARCH. 10.1111/jpi.12964
Arterial smooth muscle cell PKD2 (TRPP1) channels regulate systemic blood pressure (2018) eLife. 10.7554/eLife.42628
Maternal High-Fructose Intake Induces Multigenerational Activation of the Renin-Angiotensin-Aldosterone System (2019) HYPERTENSION. 10.1161/HYPERTENSIONAHA.119.12941
Rescuing vascular dysfunction in dorsal pancreatic arteries prevents tacrolimus-induced glucose metabolism disorder in mice (2025) MOLECULAR MEDICINE. 10.1186/s10020-025-01282-7
Effect of Lactobacillus casei fermented milk on fracture healing in osteoporotic mice (2022) Frontiers in Endocrinology. 10.3389/fendo.2022.1041647
ACE2 deficiency inhibits thoracic aortic dissection by enhancing SIRT3 mediated inhibition of inflammation and VSCMs phenotypic switch (2024) MOLECULAR MEDICINE. 10.1186/s10020-024-00926-4
Bone morphogenetic protein 4 in perivascular adipose tissue ameliorates hypertension through regulation of angiotensinogen (2022) Frontiers in Cardiovascular Medicine. 10.3389/fcvm.2022.1038176
Tacrolimus Induced Hypertension and Vascular Remodeling Includes Mechanisms of Cellular Senescence—The Protective Effect of Valsartan (2026) Acta Physiologica. 10.1111/apha.70189
LncRNA HOX transcript antisense RNA mitigates cardiac function injury in chronic heart failure via regulating microRNA-30a-5p to target KDM3A (2022) JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 10.1111/jcmm.17160
Apela inhibits systemic and renal inflammatory reactions in mice with type I cardiorenal syndrome (2021) FASEB JOURNAL. 10.1096/fj.202101030R
Short-Term Hyperuricemia Leads to Structural Retinal Changes That Can be Reversed by Serum Uric Acid Lowering Agents in Mice (2022) INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 10.1167/iovs.63.10.8
Synergistic effect of collagen peptide LR-7 and taurine on the prevention of cardiovascular injury in high salt-induced hypertensive mice (2024) Food Bioscience. 10.1016/j.fbio.2024.104907
Gut microbiota dysbiosis affects the local renin-angiotensin system to induce osteoporosis (2025) Frontiers in Endocrinology. 10.3389/fendo.2025.1698719
Cardiomyocytes FGFBP1 induction by STAT3 drives pathological cardiac remodeling (2026) BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 10.1016/j.bbadis.2026.168269
Silenced long non-coding RNA RMST ameliorates cardiac dysfunction and inflammatory response in doxorubicin-induced heart failure in C57BL/6 mice via the modulation of the microRNA-10b-5p/TRAF6 axis (2024) JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY. 10.1007/s13105-024-01056-5
LncRNA TUG1 Exacerbates Myocardial Fibrosis in Diabetic Cardiomyopathy by Modulating the microRNA-145a-5p/Cfl2 Axis (2023) JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 10.1097/FJC.0000000000001391
A?aí seed extract prevents the renin-angiotensin system activation, oxidative stress and inflammation in white adipose tissue of high-fat diet–fed mice (2020) NUTRITION RESEARCH. 10.1016/j.nutres.2020.05.006
Salidroside Pre-Treatment Inhibits Hypertensive Renal Injury and Fibrosis Through Inhibiting Wnt/β-Catenin Pathway (2024) Dose-Response. 10.1177/15593258241298045
Targeting miR-144-5p/ACSM1 Axis Alleviates Doxorubicin-Induced Heart Failure by Inhibiting Lipid Peroxidation (2025) Current Medical Science. 10.1007/s11596-025-00053-z
Maternal high-fructose intake during pregnancy and lactation induces metabolic syndrome in adult offspring (2020) Nutrition Research and Practice. 10.4162/nrp.2021.15.2.160
